28/03/2008
ReGen Therapeutics Plc (‘ReGen’ or the ‘Company’, AIM: RGT) is pleased to announce that further to the placing of 629,685 new ordinary shares which was announced on 26 March 2008 (‘the Placing’), and in order to satisfy market demand, a further placing (‘the Further Placing’) has been arranged.
The Company has today placed through Alexander David Securities Limited, 130,000 new ordinary shares of 10p each at 32.5p per share, (the same terms as the Placing) and as a result has raised £42,250 before expenses of the issue.
In addition, ReGen has today issued 138,889 new ordinary shares to Duke Holdings Corporation Limited (‘Duke’) as payment of the drawdown fees under the equity credit facility agreement announced on 26 March 2008.
The total of 268,889 new ordinary shares, which will represent 2.41% per cent of the enlarged issued share capital of the Company, will rank pari passu in all respects with the existing ordinary shares in the Company.
Application will be made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and dealings in the new ordinary shares are expected to commence on 2 April 2008.
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel No 020 7628 3396
David Scott/Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9800